CoChat

HSP72 Is a Mitochondrial Stress Sensor Critical for Parkin Action, Oxidative Metabolism, and Insulin Sensitivity in Skeletal Muscle

Open access

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

Increased heat shock protein (HSP) 72 expression in skeletal muscle prevents obesity and glucose intolerance in mice, although the underlying mechanisms of this observation are largely unresolved. Herein we show that HSP72 is a critical regulator of stress-induced mitochondrial triage signaling since Parkin, an E3 ubiquitin ligase known to regulate mitophagy, was unable to ubiquitinate and control its own protein expression or that of its central target mitofusin (Mfn) in the absence of HSP72. In wild-type cells, we show that HSP72 rapidly translocates to depolarized mitochondria prior to Parkin recruitment and immunoprecipitates with both Parkin and Mfn2 only after specific mitochondrial insult. In HSP72 knockout mice, impaired Parkin action was associated with retention of enlarged, dysmorphic mitochondria and paralleled by reduced muscle respiratory capacity, lipid accumulation, and muscle insulin resistance. Reduced oxygen consumption and impaired insulin action were recapitulated in Parkin-null myotubes, confirming a role for the HSP72-Parkin axis in the regulation of muscle insulin sensitivity. These data suggest that strategies to maintain HSP72 may provide therapeutic benefit to enhance mitochondrial quality and insulin action to ameliorate complications associated with metabolic diseases, including type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db13-0665

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 HSP72-KO promotes glucose intolerance and insulin resistance in male mice. A: Immunoblot analyses performed on glucoregulatory tissues (white adipose tissue, liver, and muscle) confirms deletion of HSP72 in HSP72-KO tissues under basal and heat shock conditions. B: Glucose tolerance is impaired in KO mice (closed circles, dotted line) compared with WT (open circles, solid line; n = 10 mice/genotype). Hyperinsulinemic-euglycemic clamp studies show skeletal muscle and hepatic insulin resistance in HSP72-KO mice (closed bars; n = 8) as (C) insulin-stimulated glucose disposal rate and (D) hepatic glucose production (HGP) percentage suppression was significantly reduced compared with WT (open bars; n = 7 mice). E: Studies in isolated skeletal muscle (soleus) show impaired insulin-stimulated glucose uptake (n = 8 mice/genotype) and (F) reduced insulin-stimulated phosphorylation of Akt in HSP72-KO (closed bars) versus WT (open bars). G: Fatty acid oxidation was reduced, and (H) fatty acid esterification increased in isolated soleus muscles from HSP72-KO (closed bars) compared with WT (open bars) mice (n = 6/genotype). I: AMPK activity in quadriceps from WT and HSP72-KO mice (n = 6 mice/genotype). J: Diacylglycerol and triacylglycerol levels were elevated significantly in muscle from HSP72-KO (closed bars) versus WT (open bars; n = 6 mice/genotype) as measured by mass spectrometry. Values are expressed as means ± SEM. *, significance, P < 0.05, between genotypes; #, significance, P < 0.05, within genotype, between treatments. WAT, white adipose tissue; AUC, area under the curve; DAG, diacylglycerol; FA, fatty acid; HGP, hepatic glucose production; IS, insulin-stimulated; IS-GDR, insulin-stimulated glucose disposal rate; TAG, triacylglycerol; WAT, white adipose tissue.
Figure 1 HSP72-KO promotes glucose intolerance and insulin resistance in male mice. A: Immunoblot analyses performed on glucoregulatory tissues (white adipose tissue, liver, and muscle) confirms deletion of HSP72 in HSP72-KO tissues under basal and heat shock conditions. B: Glucose tolerance is impaired in KO mice (closed circles, dotted line) compared with WT (open circles, solid line; n = 10 mice/genotype). Hyperinsulinemic-euglycemic clamp studies show skeletal muscle and hepatic insulin resistance in HSP72-KO mice (closed bars; n = 8) as (C) insulin-stimulated glucose disposal rate and (D) hepatic glucose production (HGP) percentage suppression was significantly reduced compared with WT (open bars; n = 7 mice). E: Studies in isolated skeletal muscle (soleus) show impaired insulin-stimulated glucose uptake (n = 8 mice/genotype) and (F) reduced insulin-stimulated phosphorylation of Akt in HSP72-KO (closed bars) versus WT (open bars). G: Fatty acid oxidation was reduced, and (H) fatty acid esterification increased in isolated soleus muscles from HSP72-KO (closed bars) compared with WT (open bars) mice (n = 6/genotype). I: AMPK activity in quadriceps from WT and HSP72-KO mice (n = 6 mice/genotype). J: Diacylglycerol and triacylglycerol levels were elevated significantly in muscle from HSP72-KO (closed bars) versus WT (open bars; n = 6 mice/genotype) as measured by mass spectrometry. Values are expressed as means ± SEM. *, significance, P < 0.05, between genotypes; #, significance, P < 0.05, within genotype, between treatments. WAT, white adipose tissue; AUC, area under the curve; DAG, diacylglycerol; FA, fatty acid; HGP, hepatic glucose production; IS, insulin-stimulated; IS-GDR, insulin-stimulated glucose disposal rate; TAG, triacylglycerol; WAT, white adipose tissue.CC BY-NC-ND · PubMed Central
Figure 2 HSP72 deletion promotes insulin resistance and impaired fatty acid metabolism in myotubes. Primary myotubes from HSP72-KO mice (closed bars) show (A) reduced expression of hspa1a and (B) HSP72 protein after heat shock compared with cells from WT mice (open bars), measured by qPCR and immunoblotting, respectively. Impaired insulin action in HSP72-KO myotubes (closed bars) as shown by (C) reduced cellular glucose uptake and (D) impaired insulin-stimulated phosphorylation of Akt compared with WT (open bars; 5–8 observations/dose/genotype), as measured by densitometric analysis of immunoblotting (n = 3 representative samples run on same gel). Similar to findings in isolated soleus muscle, cultured myotubes from HSP72-KO mice show (E) reduced oxidation and (F) increased esterification of fatty acids. Consistent with impaired mitochondrial substrate handling, (G) real-time respirometry showed reduced basal and maximal O2 consumption in HSP72-KO cells (closed bars), compared with WT (open bars; n = 3 × 12 wells per genotype). H: HSP72 protein detected by immunoblotting in C2C12 cells infected with a lentivirus expressing either control scrambled shRNA (control scrambled) or two separate shRNAs against Hspa1b, KD(a), and KD(b). I and J: Impaired fatty acid oxidation and increased esterification in HSP72-KD cells treated with labeled palmitate. K: Similar to primary cells, real-time respirometry at basal and during maximal stimulation showed reduced O2 consumption in C2C12 myotubes with HSP72-KD (closed bars) versus control scrambled (open bars). Increased reactive oxygen species production, (L) superoxide, and (M) H2O2, in both HSP72-KD cell lines (closed bars) compared with control scrambled (open bar), as measured by MitoSOX and DCF fluorescence, respectively (n = 3 in triplicate/condition). Values are expressed as means ± SEM. *, significance, P < 0.05, between genotypes; #, significance, P < 0.05, within genotype, between treatments. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Max, maximum; rel., relative; Scr, scrambled.
Figure 2 HSP72 deletion promotes insulin resistance and impaired fatty acid metabolism in myotubes. Primary myotubes from HSP72-KO mice (closed bars) show (A) reduced expression of hspa1a and (B) HSP72 protein after heat shock compared with cells from WT mice (open bars), measured by qPCR and immunoblotting, respectively. Impaired insulin action in HSP72-KO myotubes (closed bars) as shown by (C) reduced cellular glucose uptake and (D) impaired insulin-stimulated phosphorylation of Akt compared with WT (open bars; 5–8 observations/dose/genotype), as measured by densitometric analysis of immunoblotting (n = 3 representative samples run on same gel). Similar to findings in isolated soleus muscle, cultured myotubes from HSP72-KO mice show (E) reduced oxidation and (F) increased esterification of fatty acids. Consistent with impaired mitochondrial substrate handling, (G) real-time respirometry showed reduced basal and maximal O2 consumption in HSP72-KO cells (closed bars), compared with WT (open bars; n = 3 × 12 wells per genotype). H: HSP72 protein detected by immunoblotting in C2C12 cells infected with a lentivirus expressing either control scrambled shRNA (control scrambled) or two separate shRNAs against Hspa1b, KD(a), and KD(b). I and J: Impaired fatty acid oxidation and increased esterification in HSP72-KD cells treated with labeled palmitate. K: Similar to primary cells, real-time respirometry at basal and during maximal stimulation showed reduced O2 consumption in C2C12 myotubes with HSP72-KD (closed bars) versus control scrambled (open bars). Increased reactive oxygen species production, (L) superoxide, and (M) H2O2, in both HSP72-KD cell lines (closed bars) compared with control scrambled (open bar), as measured by MitoSOX and DCF fluorescence, respectively (n = 3 in triplicate/condition). Values are expressed as means ± SEM. *, significance, P < 0.05, between genotypes; #, significance, P < 0.05, within genotype, between treatments. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Max, maximum; rel., relative; Scr, scrambled.CC BY-NC-ND · PubMed Central
Figure 3 HSP72 is critical in the regulation of mitochondrial morphology, Parkin protein, and autophagic signaling in response to cellular stress. A: Electron micrographs of soleus muscle from WT (top panels) and KO (bottom panels) mice showing intermyofibrillar (left panels, low magnification; middle panels, high magnification) and subsarcolemmal (right panels) mitochondria (n = 4/genotype). B: Increased Parkin in quadriceps muscle from 9-month-old HSP72-KO versus WT mice shown by immunoblotting (n = 4 representative animals/genotype) and corresponding densitometry (n = 10/genotype). C: Immunoblotting performed on primary myotubes from mice shows increased Parkin protein at 50 kDa in HSP72-KO versus WT (immunoblot is from the same gel). D: Immunoblotting and densitometric analyses (below) performed on C2C12 myotubes show increased Parkin protein and impaired autophagic signaling, including increased p62 and LC3BI, and reduced Beclin and Lamp1 in HSP72-KD versus control scrambled cells (all immunoblots are from the same gel; n = 3–6/genotype). E: qPCR performed on muscle from WT and HSP72-KO mice under fed and starved (24 h) conditions shows blunted induction of p62 and LC3B in KO muscle following nutrient deprivation (n = 6/genotype). F: Immunoblotting of quadriceps muscle from fed and starved (24 h) WT and HSP72-KO mice (n = 3 representative samples/genotype/condition, upper panel; densitometric analyses, lower panel; n = 4–6 samples/genotype) show similar impairments in autophagic signaling as seen in cultured cells (all immunoblots are from the same gel and, in several instances, the membranes were cut, stripped, and reprobed to maximize the data obtained from each sample). Values are expressed as means ± SEM. *, significance, P < 0.05, between genotypes; #, significance, P < 0.05, within genotype, between treatments. Cont, control; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IM, intermyofibrillar; Scr, scrambled; SS, subsarcolemmal.
Figure 3 HSP72 is critical in the regulation of mitochondrial morphology, Parkin protein, and autophagic signaling in response to cellular stress. A: Electron micrographs of soleus muscle from WT (top panels) and KO (bottom panels) mice showing intermyofibrillar (left panels, low magnification; middle panels, high magnification) and subsarcolemmal (right panels) mitochondria (n = 4/genotype). B: Increased Parkin in quadriceps muscle from 9-month-old HSP72-KO versus WT mice shown by immunoblotting (n = 4 representative animals/genotype) and corresponding densitometry (n = 10/genotype). C: Immunoblotting performed on primary myotubes from mice shows increased Parkin protein at 50 kDa in HSP72-KO versus WT (immunoblot is from the same gel). D: Immunoblotting and densitometric analyses (below) performed on C2C12 myotubes show increased Parkin protein and impaired autophagic signaling, including increased p62 and LC3BI, and reduced Beclin and Lamp1 in HSP72-KD versus control scrambled cells (all immunoblots are from the same gel; n = 3–6/genotype). E: qPCR performed on muscle from WT and HSP72-KO mice under fed and starved (24 h) conditions shows blunted induction of p62 and LC3B in KO muscle following nutrient deprivation (n = 6/genotype). F: Immunoblotting of quadriceps muscle from fed and starved (24 h) WT and HSP72-KO mice (n = 3 representative samples/genotype/condition, upper panel; densitometric analyses, lower panel; n = 4–6 samples/genotype) show similar impairments in autophagic signaling as seen in cultured cells (all immunoblots are from the same gel and, in several instances, the membranes were cut, stripped, and reprobed to maximize the data obtained from each sample). Values are expressed as means ± SEM. *, significance, P < 0.05, between genotypes; #, significance, P < 0.05, within genotype, between treatments. Cont, control; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IM, intermyofibrillar; Scr, scrambled; SS, subsarcolemmal.CC BY-NC-ND · PubMed Central
Figure 4 HSP72, Parkin, and insulin action. A: Representative immunoblots and densitometry for HSP72-KO myotubes infected with control empty virus or HSP72 adenovirus show reduction of Parkin protein following HSP72 reconstitution (n = 5 experiments/condition; n = 3 representative blots/condition). B: Immunoblots of Parkin and HSP72 protein from soleus muscle of WT and HSP72-KO mice (n = 3/genotype) electroporated with GFP (right leg) or HSP72 expression plasmid (left leg). C: Representative immunoblots (n = 2 /genotype) and densitometry (n = 10/per genotype) of Parkin from WT (open bars), HSP72+/− (gray bars), and HSP72−/− (closed bars) mice. D: Representative immunoblots of Parkin protein in primary myotubes from WT and Parkin-KO mice (n = 6/genotype). E: Real-time respirometry showing reduced maximal respiration in primary myotubes from Parkin-KO versus WT mice (n = 6/genotype). F: Impaired insulin-stimulated (10 nmol/L) glucose uptake and (G) insulin signaling (1 and 10 nmol/L) in Parkin-KO versus WT myotubes (n = 3 observations performed in duplicate; n = 2 representative blots/condition). Values are expressed as means ± SEM. *, significance, P < 0.05, between genotypes; #, significance, P < 0.05, within genotype, between treatments. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
Figure 4 HSP72, Parkin, and insulin action. A: Representative immunoblots and densitometry for HSP72-KO myotubes infected with control empty virus or HSP72 adenovirus show reduction of Parkin protein following HSP72 reconstitution (n = 5 experiments/condition; n = 3 representative blots/condition). B: Immunoblots of Parkin and HSP72 protein from soleus muscle of WT and HSP72-KO mice (n = 3/genotype) electroporated with GFP (right leg) or HSP72 expression plasmid (left leg). C: Representative immunoblots (n = 2 /genotype) and densitometry (n = 10/per genotype) of Parkin from WT (open bars), HSP72+/− (gray bars), and HSP72−/− (closed bars) mice. D: Representative immunoblots of Parkin protein in primary myotubes from WT and Parkin-KO mice (n = 6/genotype). E: Real-time respirometry showing reduced maximal respiration in primary myotubes from Parkin-KO versus WT mice (n = 6/genotype). F: Impaired insulin-stimulated (10 nmol/L) glucose uptake and (G) insulin signaling (1 and 10 nmol/L) in Parkin-KO versus WT myotubes (n = 3 observations performed in duplicate; n = 2 representative blots/condition). Values are expressed as means ± SEM. *, significance, P < 0.05, between genotypes; #, significance, P < 0.05, within genotype, between treatments. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.CC BY-NC-ND · PubMed Central
Figure 5 HSP72 translocates to damaged mitochondria and regulates Parkin-mediated mitophagic signaling. A: Immunoblotting for Parkin in soluble (+) and pellet (–) fractions from WT and HSP72-KO mouse quadriceps (n = 3/genotype) shows that Parkin resides in the soluble fraction in HSP72-KO muscle. B: Confocal images of myotubes (Parkin immunolabeled green) treated with vehicle (DMSO) or CCCP show defective Parkin translocation to mitochondria in HSP72-KO versus WT myotubes following CCCP treatment. Impaired Parkin translocation was confirmed by (C) immunoblotting of mitochondrial fractions isolated from WT and HSP72-KO myotubes treated with or without CCCP for 4 h. D: Immunoblots of cell lysates (left panel) and Parkin immunoprecipitation (right panel) in myotubes show altered Parkin ubiquitination and interaction between Mfn2 and Parkin in HSP72-KO versus WT primary myotubes in response to CCCP. These observations are supported by (E) immunoblotting in HEK293A cells transfected with Parkin and exposed to MG132, imatinib, CCCP, or starvation as indicated. F: Confocal images of N2a cells transfected with mtRFP and Parkin YFP or (G) mtRFP and HSP72 GFP and treated with vehicle (DMSO) or CCCP for 4 h (nuclei stained with DAPI). H and I: Immunoblots of HEK293A cell treated with or without CCCP, Baf, or MG132; (H) lysates and V5 immunoprecipitation following transfection with Parkin and V5 Mfn2 or (I) lysates and HA immunoprecipitation following transfection with HA Parkin and V5 Mfn2. Immunoblots contained in boxes are from the same gel, respectively. Reciprocal immunoprecipitation studies were performed in duplicate while all other studies were performed in triplicate. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IP, immunoprecipitation; MG, MG132; STV, starvation; Ubiq., ubiquitination; Veh, vehicle.
Figure 5 HSP72 translocates to damaged mitochondria and regulates Parkin-mediated mitophagic signaling. A: Immunoblotting for Parkin in soluble (+) and pellet (–) fractions from WT and HSP72-KO mouse quadriceps (n = 3/genotype) shows that Parkin resides in the soluble fraction in HSP72-KO muscle. B: Confocal images of myotubes (Parkin immunolabeled green) treated with vehicle (DMSO) or CCCP show defective Parkin translocation to mitochondria in HSP72-KO versus WT myotubes following CCCP treatment. Impaired Parkin translocation was confirmed by (C) immunoblotting of mitochondrial fractions isolated from WT and HSP72-KO myotubes treated with or without CCCP for 4 h. D: Immunoblots of cell lysates (left panel) and Parkin immunoprecipitation (right panel) in myotubes show altered Parkin ubiquitination and interaction between Mfn2 and Parkin in HSP72-KO versus WT primary myotubes in response to CCCP. These observations are supported by (E) immunoblotting in HEK293A cells transfected with Parkin and exposed to MG132, imatinib, CCCP, or starvation as indicated. F: Confocal images of N2a cells transfected with mtRFP and Parkin YFP or (G) mtRFP and HSP72 GFP and treated with vehicle (DMSO) or CCCP for 4 h (nuclei stained with DAPI). H and I: Immunoblots of HEK293A cell treated with or without CCCP, Baf, or MG132; (H) lysates and V5 immunoprecipitation following transfection with Parkin and V5 Mfn2 or (I) lysates and HA immunoprecipitation following transfection with HA Parkin and V5 Mfn2. Immunoblots contained in boxes are from the same gel, respectively. Reciprocal immunoprecipitation studies were performed in duplicate while all other studies were performed in triplicate. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IP, immunoprecipitation; MG, MG132; STV, starvation; Ubiq., ubiquitination; Veh, vehicle.CC BY-NC-ND · PubMed Central
Figure 6 HSP72 is a mitochondrial stress sensor. A: Confocal images of HEK293A cells transfected with HSP72 GFP/mtRFP (top panels) and Parkin YFP/mtRFP (bottom panels) over a 120-min treatment with CCCP (nuclei stained with DAPI). B: Immunoblots performed on mitochondrial preps from HEK293A cells show the presence of mitochondrial Parkin and HSP72 concomitant with a reduction in the mitochondrial membrane-bound protein Mfn2 following 30-min/4-h CCCP treatment. C: Confocal micrographs of HEK293A cells transfected with HSP72 GFP (top panels) and Parkin YFP (bottom panels) following treatment with CCCP, rotenone, and antimycin for 0.5 h and (D) 4 h (nuclei stained with DAPI). E: Immunoblots of Parkin immunoprecipitation or Mfn2 immunoprecipitation (top two panels) or lysates (bottom panels) from HEK293A cells transfected with Parkin; treated with CCCP, rotenone, or antimycin for 1, 2, or 4 h; or starved for 4 h. F: Immunoblots of lysates from N2a cells transfected with GFP (left panels), Parkin YFP (middle panels), and Parkin + HSP72 (right panels) following treatment with vehicle (DMSO; CCCP [–]) or CCCP (+) for 12 h (immunoblots are from the same gel). Values are expressed as means ± SEM. *, significance, P < 0.05, between genotypes; #, significance, P < 0.05, within genotype, between treatments. A, C, and D: Performed twice in triplicate. B: Performed in duplicate in two independent cell lines. E: A replicative time course experiment. F: Performed twice in duplicate. Con, control; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IP, immunoprecipitation; Neg, negative; STV, starvation.
Figure 6 HSP72 is a mitochondrial stress sensor. A: Confocal images of HEK293A cells transfected with HSP72 GFP/mtRFP (top panels) and Parkin YFP/mtRFP (bottom panels) over a 120-min treatment with CCCP (nuclei stained with DAPI). B: Immunoblots performed on mitochondrial preps from HEK293A cells show the presence of mitochondrial Parkin and HSP72 concomitant with a reduction in the mitochondrial membrane-bound protein Mfn2 following 30-min/4-h CCCP treatment. C: Confocal micrographs of HEK293A cells transfected with HSP72 GFP (top panels) and Parkin YFP (bottom panels) following treatment with CCCP, rotenone, and antimycin for 0.5 h and (D) 4 h (nuclei stained with DAPI). E: Immunoblots of Parkin immunoprecipitation or Mfn2 immunoprecipitation (top two panels) or lysates (bottom panels) from HEK293A cells transfected with Parkin; treated with CCCP, rotenone, or antimycin for 1, 2, or 4 h; or starved for 4 h. F: Immunoblots of lysates from N2a cells transfected with GFP (left panels), Parkin YFP (middle panels), and Parkin + HSP72 (right panels) following treatment with vehicle (DMSO; CCCP [–]) or CCCP (+) for 12 h (immunoblots are from the same gel). Values are expressed as means ± SEM. *, significance, P < 0.05, between genotypes; #, significance, P < 0.05, within genotype, between treatments. A, C, and D: Performed twice in triplicate. B: Performed in duplicate in two independent cell lines. E: A replicative time course experiment. F: Performed twice in duplicate. Con, control; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IP, immunoprecipitation; Neg, negative; STV, starvation.CC BY-NC-ND · PubMed Central
Figure 7 Proposed role of HSP72 in stress-induced mitophagy. Mitochondrial stress induces rapid movement of HSP72 to the mitochondria, where it interacts with Mfn2 on the outer mitochondrial membrane. At a later time point, Parkin translocates to the mitochondria and complexes with HSP72 and Mfn2. Herein we show that this interaction is specific to the mitochondrial insult. In the context of HSP72 deficiency, mitochondrial stress fails to induce Parkin translocation and interaction with mitochondrial membrane proteins. Parkin, in the absence of HSP72, is unable to ubiquitinate itself or its targets, and in consequence, cytosolic Parkin and mitochondrial Mfn2 protein levels become elevated, thus promoting the fusion and retention of unhealthy mitochondria to the network. We propose that this mechanism underlies the impairments in oxidative metabolism and marked insulin resistance phenotype observed in HSP72-KO animals. FAO, fatty acid oxidation.
Figure 7 Proposed role of HSP72 in stress-induced mitophagy. Mitochondrial stress induces rapid movement of HSP72 to the mitochondria, where it interacts with Mfn2 on the outer mitochondrial membrane. At a later time point, Parkin translocates to the mitochondria and complexes with HSP72 and Mfn2. Herein we show that this interaction is specific to the mitochondrial insult. In the context of HSP72 deficiency, mitochondrial stress fails to induce Parkin translocation and interaction with mitochondrial membrane proteins. Parkin, in the absence of HSP72, is unable to ubiquitinate itself or its targets, and in consequence, cytosolic Parkin and mitochondrial Mfn2 protein levels become elevated, thus promoting the fusion and retention of unhealthy mitochondria to the network. We propose that this mechanism underlies the impairments in oxidative metabolism and marked insulin resistance phenotype observed in HSP72-KO animals. FAO, fatty acid oxidation.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Cited by

See all 152

Metadata

Authors
Drew, B. G., Ribas, V., Le, J. A., Henstridge, D. C., Phun, J., Zhou, Z., Soleymani, T., Daraei, P., Sitz, D., Vergnes, L., Wanagat, J., Reue, K., Febbraio, M. A., & Hevener, A. L.
Affiliations
  • University of California, Los Angeles (US)
  • David Geffen School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes and Hypertension, University of California, Los Angeles, Los Angeles, CA
  • Baker Heart and Diabetes Institute (AU)
Corresponding author
Hevener, Andrea L.
Venue
Diabetes
Published
2014-04-12
Volume
63
Issue
5
Pages
1488-1505
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2098703027
Cited by
145
References
59
Citations by year
2026: 11 · 2025: 5 · 2024: 10 · 2023: 12 · 2022: 11 · 2021: 13 · 2020: 15 · 2019: 6 · 2018: 20 · 2017: 13 · 2016: 17 · 2015: 6 · 2014: 6
FWCI
4.33
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Heart, Lung, and Blood Institute (P01HL090553, HL28481, P01HL028481)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, DK078760, R01DK089109, P30DK063491, R01DK078760)
  • National Center for Research Resources (S10RR026744)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords
HSP72, Parkin, mitophagy, mitochondrial stress, skeletal muscle, insulin sensitivity, mitofusin 2, mitochondrial quality control, oxidative metabolism, mitochondrial depolarization, lipid accumulation, type 2 diabetes, obesity, impaired glucose tolerance, E3 ubiquitin ligase
MeSH terms
Animals, Humans, Insulin, Insulin Resistance, Mitochondria, Oxygen Consumption, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Muscle, Skeletal, Cell Respiration, Ubiquitin-Protein Ligases, Lipid Metabolism, HSP72 Heat-Shock Proteins, Mice, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.